APA (7th ed.) Citation

CP, K., JJ, G., TP, N., R, H., JP, W., & ZS, M. (2022). Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment. Pharmaceutics, 15(1), . https://doi.org/10.3390/pharmaceutics15010128

Chicago Style (17th ed.) Citation

CP, Kerr, Grudzinski JJ, Nguyen TP, Hernandez R, Weichert JP, and Morris ZS. "Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment." Pharmaceutics 15, no. 1 (2022). https://doi.org/10.3390/pharmaceutics15010128.

MLA (9th ed.) Citation

CP, Kerr, et al. "Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment." Pharmaceutics, vol. 15, no. 1, 2022, https://doi.org/10.3390/pharmaceutics15010128.